Extensively drug-resistant tuberculosis, Burkina Faso.
Because data from countries in Africa are limited, we measured the proportion of extensively drug-resistant (XDR) tuberculosis (TB) cases among TB patients in Burkina Faso for whom retreatment was failing. Of 34 patients with multidrug-resistant TB, 2 had an XDR TB strain. Second-line TB drugs should be strictly controlled to prevent further XDR TB increase.
Saleri
Nuccia
N
Ministry of Health National Tuberculosis Program, Ouagadougou, Burkina Faso, Italy.
Badoum
Gisele
G
Ouedraogo
Martial
M
Dembele
Sary M
SM
Nacanabo
Rachel
R
Bonkoungou
Victor
V
Cirillo
Daniela
D
Pinsi
Gabriele
G
Matteelli
Alberto
A
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D002050:Burkina Faso / Q000453:epidemiology; D024901:Drug Resistance, Multiple, Bacterial; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D013183:Sputum / Q000382:microbiology; D017211:Treatment Failure; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology
D000995:Antitubercular Agents
Lancet. 2006 Nov 4;368(9547):1575-80
17084757
Expert Rev Respir Med. 2008 Feb;2(1):47-54
20477221
Int J Tuberc Lung Dis. 2001 Oct;5(10):887-93
11605880
Trop Med Int Health. 2002 Nov;7(11):970-6
12390604
J Infect Dis. 2008 Dec 1;198(11):1582-9
18847372
Clin Infect Dis. 2008 Aug 15;47(4):496-502
18611154